Product Information
QC CHILD'S DIBROMM COLD-ALLGY is a generic product labeled by Chain Drug Marketing Association, priced at $0.0245 per ML under NDC 83324015604. Its NADAC has been published 96 times since Dec 4, 2024.
Strength
2; 5 mg/10mL; mg/10mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324015604
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/31/2024
Pharmacological Classes
Price Statistics
The NADAC for QC CHILD'S DIBROMM COLD-ALLGY has been published 96 times since Dec 4, 2024, and over the history we have for it it has risen 7.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0245 per ML |
|---|---|
| All-time high | $0.0249 (Aug 12, 2026) |
| All-time low | $0.0219 (Feb 19, 2025) |
| 52-week high | $0.0249 |
| 52-week low | $0.0227 |
| Median price | $0.0231 |
| Average price | $0.0232 |
| Largest weekly change | +2.5% (Jun 17, 2026) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Brompheniramine maleate, Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC CHILD'S DIBROMM COLD-ALLGY?
The current National Average Drug Acquisition Cost (NADAC) for QC CHILD'S DIBROMM COLD-ALLGY, manufactured by Chain Drug Marketing Association, is $0.0245 per ML (NDC 83324015604), effective Sep 30, 2026.
How has the price of QC CHILD'S DIBROMM COLD-ALLGY changed over time?
Over the history we have for it, the NADAC for QC CHILD'S DIBROMM COLD-ALLGY has risen 7.7%. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC CHILD'S DIBROMM COLD-ALLGY?
Since Dec 4, 2024, the NADAC for QC CHILD'S DIBROMM COLD-ALLGY has ranged from a low of $0.0219 (Feb 19, 2025) to a high of $0.0249 (Aug 12, 2026), with a median of $0.0231 per ML.
Are there cheaper alternatives to QC CHILD'S DIBROMM COLD-ALLGY?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM CHILD'S DIBROMM COLD-ALLGY, is $0.0225 per ML — about 8% below QC CHILD'S DIBROMM COLD-ALLGY.
Who manufactures QC CHILD'S DIBROMM COLD-ALLGY?
QC CHILD'S DIBROMM COLD-ALLGY (NDC 83324015604) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.